The COVID-19 pandemic is stressful. Emotions are running high. We are all coming to terms with many aspects of the situation: risks to physical health posed by the virus, disruptions to daily routines, struggles to find solutions to evolving challenges, and worries about the economic fallout of social-distancing and shelter-in-place orders, just to name just a few.
Rice University researchers used the Comet supercomputer at SDSC to evaluate their new molecular docking too to help improve cancer immunotherapy outcomes by identifying more effective personalized treatments.
Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.
Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.
Scientists, including UC San Diego researchers, recently relied on supercomputer simulations to better understand the reproductive mysteries of viruses and DNA.
New study finds gene therapy improved cardiac, muscle and liver function in Danon disease mouse models.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
